Literature DB >> 8177321

The stress-activated protein kinase subfamily of c-Jun kinases.

J M Kyriakis1, P Banerjee, E Nikolakaki, T Dai, E A Rubie, M F Ahmad, J Avruch, J R Woodgett.   

Abstract

The mitogen-activated protein (MAP) kinases Erk-1 and Erk-2 are proline-directed kinases that are themselves activated through concomitant phosphorylation of tyrosine and threonine residues. The kinase p54 (M(r) 54,000), which was first isolated from cycloheximide-treated rats, is proline-directed like Erks-1/2, and requires both Tyr and Ser/Thr phosphorylation for activity. p54 is, however, distinct from Erks-1/2 in its substrate specificity, being unable to phosphorylate pp90rsk but more active in phosphorylating the c-Jun transactivation domain. Molecular cloning of p54 reveals a unique subfamily of extracellularly regulated kinases. Although they are 40-45% identical in sequence to Erks-1/2, unlike Erks-1/2 the p54s are only poorly activated in most cells by mitogens or phorbol esters. However, p54s are the principal c-Jun N-terminal kinases activated by cellular stress and tumour necrosis factor (TNF)-alpha, hence they are designated stress-activated protein kinases, or SAPKs. SAPKs are also activated by sphingomyelinase, which elicits a subset of cellular responses to TNF-alpha (ref. 9). SAPKs therefore define a new TNF-alpha and stress-activated signalling pathway, possibly initiated by sphingomyelin-based second messengers, which regulates the activity of c-Jun.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8177321     DOI: 10.1038/369156a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  575 in total

Review 1.  ATF3 and stress responses.

Authors:  T Hai; C D Wolfgang; D K Marsee; A E Allen; U Sivaprasad
Journal:  Gene Expr       Date:  1999

2.  Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues in vivo: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinase kinases 4 and 7.

Authors:  A Finch; W Davis; W G Carter; J Saklatvala
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

3.  Specific inhibition of skeletal alpha-actin gene transcription by applied mechanical forces through integrins and actin.

Authors:  A M Lew; M Glogauer; C A Mculloch
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

4.  Suppression of Ras-induced apoptosis by the Rac GTPase.

Authors:  T Joneson; D Bar-Sagi
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

5.  Improved soft-agar colony assay in a fluid processing apparatus.

Authors:  A D Forsman; A R Herpich; S K Chapes
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-01       Impact factor: 2.416

6.  p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis.

Authors:  M Warny; A C Keates; S Keates; I Castagliuolo; J K Zacks; S Aboudola; A Qamar; C Pothoulakis; J T LaMont; C P Kelly
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

7.  Synergistic activation of JNK/SAPK by interleukin-1 and platelet-derived growth factor is independent of Rac and Cdc42.

Authors:  W Davis; L R Stephens; P T Hawkins; J Saklatvala
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

8.  Effect of vitamin E succinate on expression of TGF-beta1, c-Jun and JNK1 in human gastric cancer SGC-7901 cells.

Authors:  K Wu; B H Liu; D Y Zhao; Y Zhao
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

9.  Heat shock and ceramide have different apoptotic pathways in radiation induced fibrosarcoma (RIF) cells.

Authors:  Hee-Jung Kim; Kong-Joo Lee
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

10.  Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells.

Authors:  S Leppä; M Eriksson; R Saffrich; W Ansorge; D Bohmann
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.